Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1103 | 946 | 1173 | 1032 | 1521 | - |
Fund Return | 10.34% | -5.44% | 17.32% | 1.04% | 8.76% | - |
Place in category | 78 | 106 | 79 | 113 | 44 | - |
% in Category | 38 | 67 | 47 | 56 | 21 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 35.09B | 15.10 | 7.45 | 10.77 | ||
T. Rowe Price Blue Chip Growth | 32.6B | 36.09 | 7.62 | 14.78 | ||
T. Rowe Price Blue Chip Growth I | 29.84B | 36.24 | 7.76 | - | ||
T. Rowe Price Capital AppreciationI | 28.77B | 15.25 | 7.60 | - | ||
T. Rowe Price Instl Large Cap Growt | 22.6B | 32.75 | 8.37 | 16.17 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 37.96B | 5.49 | 5.82 | 7.98 | ||
Fidelity Select Health Care | 6.77B | 13.38 | 2.97 | 9.10 | ||
T. Rowe Price Health Sciences | 7.83B | 10.22 | 0.91 | 9.64 | ||
Vanguard Health Care Inv | 6.88B | 5.45 | 5.77 | 7.93 | ||
Fidelity Advisor Health Care I | 1.76B | 12.14 | 2.57 | 8.51 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.48 | 781.98 | +0.50% | |
Aggregate Miscellaneous Equity | - | 9.02 | - | - | |
UnitedHealth | US91324P1021 | 7.38 | 513.00 | +1.68% | |
Intuitive Surgical | US46120E6023 | 5.07 | 535.29 | +2.15% | |
Thermo Fisher Scientific | US8835561023 | 4.64 | 532.02 | +1.81% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review